Free Trial

Avalo Therapeutics (AVTX) Institutional Ownership

+0.36 (+3.34%)
(As of 05/23/2024 ET)

Institutional Ownership Changes (13F Filings) for Avalo Therapeutics (NASDAQ:AVTX)

Institutional Ownership
Number of
Institutional Buyers
(last 12 months)
Institutional Inflows
(last 12 months)
Number of
Institutional Sellers
(last 12 months)
Institutional Outflows
(last 12 months)
Get AVTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Avalo Therapeutics stock? Sign up for's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

AVTX Institutional Buying and Selling by Quarter

Avalo Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2024 Ikarian Capital LLC46,648$1.02M0.1%N/A4.511%
5/15/2024 Affinity Asset Advisors LLC10,000$218K0.0%N/A0.971%
5/14/2024 Natixis2,512$55K0.0%-45.4%0.244%
11/13/2023 Acadian Asset Management LLC283,306$34K0.0%N/A1.399%
8/11/2023 VR Adviser LLC1,250,000$444K0.1%+25.0%6.173%
5/16/2023 Great Point Partners LLC474,639$831K0.2%N/A3.595%
5/5/2023 Monashee Investment Management LLC60,000$105K0.0%N/A0.455%
2/15/2023 Nantahala Capital Management LLC540,667$2.73M0.2%-1.3%5.746%
11/14/2022 Armistice Capital LLC3,964,666$13.16M0.2%-91.7%42.115%
11/14/2022 Point72 Asset Management L.P.500,737$1.66M0.0%-91.7%5.319%
11/10/2022 Nantahala Capital Management LLC547,814$1.82M0.1%-91.8%5.819%
10/27/2022 Assenagon Asset Management S.A.15,646$52K0.0%N/A0.166%
8/15/2022 Nantahala Capital Management LLC6,710,327$3.36M0.2%-2.0%71.280%
8/15/2022 Opaleye Management Inc.450,000$225K0.1%-69.1%4.780%
5/12/2022 Integral Health Asset Management LLC700,000$507K0.1%-56.9%0.621%
5/3/2022Leo Brokerage LLC62,629$45K0.0%N/A0.056%
4/25/2022 Assenagon Asset Management S.A.42,338$31K0.0%-92.7%0.038%
2/15/2022 Stonepine Capital Management LLC1,510,095$2.57M1.2%+77.7%1.344%
2/15/2022 LGL Partners LLC28,850$49K0.0%N/A0.026%
2/14/2022 Freestone Capital Holdings LLC20,000$34K0.0%N/A0.018%
2/14/2022 Soleus Capital Management L.P.770,000$1.31M0.1%N/A0.686%
2/8/2022 Northern Trust Corp533,578$907K0.0%+3.1%0.475%
2/1/2022 Assenagon Asset Management S.A.582,718$991K0.0%-33.7%0.519%
1/24/2022 Strs Ohio38,400$65K0.0%-40.2%0.034%
1/20/2022Minot Wealth Management LLC34,645$59K0.0%-66.5%0.031%
12/29/2021 Hudson Bay Capital Management LP197,133$430K0.0%N/A0.176%
11/16/2021 Opaleye Management Inc.1,459,400$3.18M0.6%N/A1.299%
11/16/2021 Squarepoint Ops LLC18,657$41K0.0%N/A0.017%
11/16/2021 Two Sigma Advisers LP801,300$1.75M0.0%N/A0.713%
11/16/2021 Two Sigma Investments LP732,931$1.60M0.0%N/A0.653%
11/16/2021 Laurion Capital Management LP330,444$720K0.0%N/A0.294%
11/15/2021 Point72 Asset Management L.P.6,008,850$13.10M0.1%N/A5.350%
11/15/2021 Atom Investors LP27,507$60K0.0%N/A0.024%
11/15/2021 Voya Investment Management LLC21,854$48K0.0%N/A0.019%
11/15/2021 Caas Capital Management LP11,812$26K0.0%N/A0.011%
11/12/2021 Aristides Capital LLC48,953$107K0.0%N/A0.044%
11/12/2021 Stonepine Capital Management LLC850,000$1.85M0.8%N/A0.770%
11/12/2021 Geode Capital Management LLC1,242,382$2.71M0.0%N/A1.126%
11/12/2021 Integral Health Asset Management LLC1,625,000$3.54M1.0%N/A1.473%
11/10/2021 Goldman Sachs Group Inc.672,664$1.47M0.0%N/A0.610%
Memorial Day Sale! Get 90% OFF Behind the Markets! (Ad)

Today, I'm offering you the chance to receive a PLATINUM BTM subscription for up to 90% OFF! If you want to see just how much your mystery discount is...

11/10/2021 Creative Planning14,814$32K0.0%N/A0.013%
11/10/2021 Alliancebernstein L.P.19,100$42K0.0%N/A0.017%
11/9/2021 BlackRock Inc.3,716,943$8.10M0.0%N/A3.369%
11/9/2021 Monashee Investment Management LLC270,000$589K0.1%N/A0.245%
11/8/2021 Meeder Asset Management Inc.19,260$43K0.0%N/A0.017%
11/4/2021Asymmetry Capital Management L.P.534,621$1.17M0.7%N/A0.485%
11/4/2021 Deutsche Bank AG31,794$69K0.0%N/A0.029%
11/2/2021 Cambridge Investment Research Advisors Inc.12,164$27K0.0%N/A0.011%
11/2/2021 New York State Common Retirement Fund22,214$48K0.0%N/A0.020%
11/2/2021 Victory Capital Management Inc.15,788$34K0.0%N/A0.014%
11/1/2021 SG Americas Securities LLC18,596$41K0.0%N/A0.017%
10/29/2021Commonwealth Equity Services LLC52,000$113K0.0%N/A0.047%
10/25/2021Minot Wealth Management LLC103,410$225K0.0%N/A0.094%
10/22/2021 Strs Ohio64,200$139K0.0%N/A0.058%
10/19/2021 Assenagon Asset Management S.A.879,334$1.92M0.0%N/A0.797%
10/19/2021 Tamar Securities LLC23,084$50K0.0%N/A0.021%
(Data available from 1/1/2016 forward)

AVTX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of AVTX shares?

During the previous two years, 12 institutional investors and hedge funds held shares of Avalo Therapeutics. The most heavily invested institutionals were Armistice Capital LLC ($13.16M), Nantahala Capital Management LLC ($2.73M), Point72 Asset Management L.P. ($1.66M), Ikarian Capital LLC ($1.02M), Great Point Partners LLC ($831K), VR Adviser LLC ($444K), and Opaleye Management Inc. ($225K).Learn more on AVTX's institutional investors.

What percentage of Avalo Therapeutics stock is owned by institutional investors?

87.06% of Avalo Therapeutics stock is owned by institutional investors. Learn more on AVTX's institutional investor holdings.

Which institutional investors have been buying Avalo Therapeutics stock?

The following institutional investors have purchased Avalo Therapeutics stock in the last 24 months: Great Point Partners LLC ($474.64K), Acadian Asset Management LLC ($283.31K), VR Adviser LLC ($250K), Monashee Investment Management LLC ($60K), Ikarian Capital LLC ($46.65K), Assenagon Asset Management S.A. ($15.65K), and Affinity Asset Advisors LLC ($10K).

How much institutional buying is happening at Avalo Therapeutics?

Institutional investors have bought a total of 1,140,239 shares in the last 24 months. This purchase volume represents approximately $267.77M in transactions.

Which Avalo Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Avalo Therapeutics stock in the last 24 months: Armistice Capital LLC ($43.61M), Nantahala Capital Management LLC ($6.31M), Point72 Asset Management L.P. ($5.51M), Opaleye Management Inc. ($1.00M), and Natixis ($2.09K).

How much institutional selling is happening at Avalo Therapeutics?

Institutional investors have sold a total of 56,434,819 shares in the last 24 months. This volume of shares sold represents approximately $45.70B in transactions.

This page (NASDAQ:AVTX) was last updated on 5/24/2024 by Staff

From Our Partners